Most not long ago, it's been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor functions for a scavenger and does not activate a secon